![]() |
产地 | |
品牌 | Invitrogen |
货号 | CMAX00008 |
用途 | 科研实验 |
英文名称 | |
包装规格 | |
纯度 | % |
CAS编号 | |
保质期 | 一年 |
是否进口 | 否 |
Optimized protocols provide minimal cell toxicity
CRISPR RNP—streamlined editing and minimization of off-target events
A CRISPR-Cas9 targeted double-strand break
Engineered nuclease—various double strand repair pathways
Standard gene editing workflow using CRISPR-Cas9 technology
Factors affecting genome editing efficiency outcomes
Invitrogen CRISPR genome-editing tools outperform other suppliers
Unravel the complexities of cancer cells with robust CRISPR gene editing
Robust CRISPR gene editing in THP-1 cells
细胞类型: | 原代细胞 |
---|---|
适用于(应用): | Transfection |
样品类型: | 蛋白质 |
Transfection Technique: | 脂质体介导转染 |
产品类型: | Transfection Reagent |
数量: | 75 rxn |
分类: | 无动物来源 |
血清兼容性: | 是 |
运输条件: | 经批准可在室温下或置于湿冰上运输 |
产品线: | CRISPRMAX™、Lipofectamine™ |